Literature DB >> 18403372

Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis.

Mitsumi Arito1, Taro Horiba, Satoshi Hachimura, Jun Inoue, Ryuichiro Sato.   

Abstract

The destiny and activity of sterol regulatory element-binding proteins (SREBPs) in the nucleus are regulated by modification with ubiquitin, small ubiquitin-like modifier (SUMO), or phosphorus. ERK-dependent phosphorylation causes an increase in their transcriptional activity, whereas SUMO modification halts it. We hypothesized a causal linkage between phosphorylation and sumoylation because their sites are very closely located in SREBP-1 and -2 molecules. When Ser(455), a phosphorylation site in SREBP-2, was substituted with Ala, this SREBP-2 mutant was more efficiently modified by SUMO-1. On the other hand, substitution of Asp inhibited SUMO conjugation, mimicking phosphoserine. When cells were cultured with insulin-like growth factor-1, sumoylation of SREBP-2 was decreased with an increase in its phosphorylation, but SREBP-2(S455A) was continuously sumoylated. An ERK cascade inhibitor, U0126, inversely augmented SUMO modification of SREBP-2. Insulin-like growth factor-1 treatment stimulated the expression of SREBP target genes such as the low density lipoprotein (LDL) receptor, squalene synthase, and hydroxymethylglutaryl-CoA synthase genes. These results indicate that growth factor-induced phosphorylation of SREBP-2 inhibits sumoylation, thereby facilitating SREBP transcriptional activity. Glutathione S-transferase pulldown assays revealed that wild-type SREBP-2, but not a mutant lacking Lys(464), interacts with HDAC3 preferentially among the histone deacetylase family members. HDAC3 small interfering RNA induced gene expression of the LDL receptor and thereby augmented fluorescently labeled LDL uptake in HepG2 cells. In summary, growth factors inhibit sumoylation of SREBPs through their phosphorylation, thus avoiding the recruitment of an HDAC3 corepressor complex and stimulating the lipid uptake and synthesis required for cell growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403372      PMCID: PMC3258893          DOI: 10.1074/jbc.M800910200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway.

Authors:  Y Hirano; M Yoshida; M Shimizu; R Sato
Journal:  J Biol Chem       Date:  2001-07-27       Impact factor: 5.157

2.  Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.

Authors:  Shen-Hsi Yang; Ellis Jaffray; Ron T Hay; Andrew D Sharrocks
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

3.  Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade.

Authors:  J Kotzka; D Müller-Wieland; G Roth; L Kremer; M Munck; S Schürmann; B Knebel; W Krone
Journal:  J Lipid Res       Date:  2000-01       Impact factor: 5.922

4.  Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway.

Authors:  J V Swinnen; H Heemers; L Deboel; F Foufelle; W Heyns; G Verhoeven
Journal:  Oncogene       Date:  2000-10-26       Impact factor: 9.867

5.  Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.

Authors:  Juraj Bies; Ján Markus; Linda Wolff
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

6.  P300 transcriptional repression is mediated by SUMO modification.

Authors:  David Girdwood; Donna Bumpass; Owen A Vaughan; Alison Thain; Lisa A Anderson; Andrew W Snowden; Elisa Garcia-Wilson; Neil D Perkins; Ronald T Hay
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

7.  Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway.

Authors:  Yuko Hirano; Shigeo Murata; Keiji Tanaka; Makoto Shimizu; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2003-03-02       Impact factor: 5.157

8.  PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.

Authors:  Tamotsu Nishida; Hideyo Yasuda
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

9.  Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.

Authors:  Junsoo Park; Kwangsoo Kim; Eun-Ju Lee; Yun-Jee Seo; Si-Nae Lim; Kyoungsook Park; Seung Bae Rho; Seung-Hoon Lee; Je-Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation.

Authors:  Hyun-Jin Shin; Kwan-Hyuck Baek; Ae-Hwa Jeon; So-Jung Kim; Kyung-Lib Jang; Young-Chul Sung; Chang-Min Kim; Chang-Woo Lee
Journal:  Oncogene       Date:  2003-06-19       Impact factor: 9.867

View more
  21 in total

1.  PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.

Authors:  Gha Young Lee; Hagoon Jang; Jae Ho Lee; Jin Young Huh; Sekyu Choi; Jongkyeong Chung; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

Review 2.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis.

Authors:  Haojie Yu; Antoine Rimbert; Alice E Palmer; Takafumi Toyohara; Yulei Xia; Fang Xia; Leonardo M R Ferreira; Zhifen Chen; Tao Chen; Natalia Loaiza; Nathaniel Brooks Horwitz; Michael C Kacergis; Liping Zhao; Alexander A Soukas; Jan Albert Kuivenhoven; Sekar Kathiresan; Chad A Cowan
Journal:  Cell       Date:  2019-11-27       Impact factor: 41.582

4.  A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation.

Authors:  Virginie Lecomte; Emmanuelle Meugnier; Vanessa Euthine; Christine Durand; Damien Freyssenet; Georges Nemoz; Sophie Rome; Hubert Vidal; Etienne Lefai
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

Review 5.  PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol.

Authors:  Devina Mehta; Kamal D Mehta
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-19       Impact factor: 4.052

6.  Diabetes and insulin in regulation of brain cholesterol metabolism.

Authors:  Ryo Suzuki; Kevin Lee; Enxuan Jing; Sudha B Biddinger; Jeffrey G McDonald; Thomas J Montine; Suzanne Craft; C Ronald Kahn
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

7.  The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8 hampers ER to Golgi transport of sterol regulatory element-binding protein-2 (SREBP-2)/SREBP cleavage-activated protein and reduces SREBP-2 cleavage.

Authors:  Masato Irisawa; Jun Inoue; Nozomi Ozawa; Kazutoshi Mori; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

8.  Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.

Authors:  Andrea R Daniel; Carol A Lange
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

9.  Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.

Authors:  Rebecca Schneider Aguirre; Saul J Karpen
Journal:  Mol Pharmacol       Date:  2013-05-20       Impact factor: 4.436

10.  Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.

Authors:  Carla Maria P Ribeiro; Harry Hurd; Yichao Wu; Mary E B Martino; Lisa Jones; Brian Brighton; Richard C Boucher; Wanda K O'Neal
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.